Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder

ClinicalTrials.gov ID: NCT01674010

Public ClinicalTrials.gov record NCT01674010. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 10:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Safety and Efficacy Study of Oral ELND005 as an Adjunctive Maintenance Treatment in Patients With Bipolar I Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to determine whether ELND005 is effective in the maintenance treatment of bipolar 1 disorder when added to other therapies.

Study identification

NCT ID
NCT01674010
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
OPKO Health, Inc.
Industry
Enrollment
309 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2012
Primary completion
May 31, 2014
Completion
May 31, 2014
Last update posted
Oct 20, 2019

2012 – 2014

United States locations

U.S. sites
41
U.S. states
19
U.S. cities
39
Facility City State ZIP Site status
Elan Investigational Site Birmingham Alabama 35294
Elan Investigational Site Glendale Arizona 85306
Elan Investigational Site Phoenix Arizona 85004
Elan Investigational Site Little Rock Arkansas 72201
Elan Investigational Site Little Rock Arkansas 72211
Elan Investigational Site Cerritos California 90703
Elan Investigational Site Costa Mesa California 92626
Elan Investigational Site Escondido California 92025
Elan Investigational Site Garden Grove California 92845
Elan Investigational Site National City California 91950
Elan Investigational Site Oceanside California 92056
Elan Investigational Site Palo Alto California 94304
Elan Investigational Site Riverside California 92506
Elan Investigational Site San Diego California 92121
Elan Investigational Site Santa Ana California 92701
Elan Investigational Site Stanford California 94305
Elan Investigational Site Norwich Connecticut 06360
Elan Investigational Site North Miami Florida 33161
Elan Investigational Site Oakland Park Florida 33334
Elan Investigational Site Tampa Florida 33613
Elan Investigational Site Atlanta Georgia 30308
Elan Investigational Site Roswell Georgia 30076
Elan Investigational Site Creve Coeur Missouri 63141
Elan Investigational Site St Louis Missouri 63118
Elan Investigational Site St Louis Missouri 63128
Elan Investigational Site Lincoln Nebraska 68526
Elan Investigational Site Marlton New Jersey 08053
Elan Investigational Site Fresh Meadows New York 11366
Elan Investigational Site New York New York 10065
Elan Investigational Site Raleigh North Carolina 27609
Elan Investigational Site Beachwood Ohio 44122
Elan Investigational Site Cincinnati Ohio 45219
Elan Investigational Site Cleveland Ohio 44106
Elan Investigational Site Oklahoma City Oklahoma 73112
Elan Investigational Site Philadelphia Pennsylvania 19139
Elan Investigational Site Charleston South Carolina 29407
Elan Investigational Site Houston Texas 77054
Elan Investigational Site Hurst Texas 76053
Elan Investigational Site San Antonio Texas 78229
Elan Investigational Site Salt Lake City Utah 84106
Elan Investigational Site Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01674010, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 20, 2019 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01674010 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →